4 results  1 of 1 

1 Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea
So Young Park, Se Hwa Kim, Tae-Young Kim, Young-Kyun Lee, Yong-Chan Ha, Sunmee Jang, Seong Hee Ahn, Ha Young Kim
J Korean Med Sci.2021;36(27):e186.  Published online 2021 June 21     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e186
      
2 Influence of Supplementary Vitamin D on Bone Mineral Density When Used in Combination with Selective Estrogen Receptor Modulators
Hyun Ju Liu, Soo Ah Kim, Da Joung Shim, Ji Min Jung, Eun Jeong Lee
J Menopausal Med.2019;25(2):94-99.   Published online 2019 July 23     DOI: http://dx.doi.org/10.6118/jmm.19193
      
3 Uterine Malignant Mixed Müllerian Tumors Following Treatment with Selective Estrogen Receptor Modulators in Patients with Breast Cancer: A Report of 13 Cases and Their Clinicopathologic Characteristics
Byung-Kwan Jeong, Chang O. Sung, Kyu-Rae Kim
J Pathol Transl Med.2019;53(1):31-39.   Published online 2018 December 18     DOI: http://dx.doi.org/10.4132/jptm.2018.11.16
      
4 Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
Jin Park, Ju-Ik Kim, Seok-Kweon Yun, Han-Uk Kim, Chull-Wan Ihm
Ann Dermatol.2014;26(6):743-746.   Published online 2014 November 26     DOI: http://dx.doi.org/10.5021/ad.2014.26.6.743
      

 1 of 1